Praxis Precision Medicines, Inc. (PRAX) Revenue (2023 - 2024)
Praxis Precision Medicines (PRAX) posted quarterly Revenue of $7.5 million for Q4 2024, up 1349.13% year-over-year from $515000.0 in Q1 2024, and up 2371.19% on a QoQ basis from $302000.0 in Q3 2024.
Praxis Precision Medicines, Inc. (PRAX) Revenue (2023 - 2024) Analysis & Trends
Praxis Precision Medicines (PRAX) has reported Revenue for 2 consecutive years, with $7.5 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Revenue rose 1349.13% year-over-year to $7.5 million; the TTM figure through Sep 2025 stood at $7.5 million (up 364.98% YoY), while the FY2024 annual figure was $8.6 million, up 249.53% from the prior year.
- Revenue came in at $7.5 million for Q4 2024 at Praxis Precision Medicines, up from $302000.0 in the prior quarter.
- The five-year high for Revenue was $7.5 million in Q4 2024, with the low at $302000.0 in Q3 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7.46 Mn |
| Sep 30, 2024 | 302,000.00 |
| Jun 30, 2024 | 357,000.00 |
| Mar 31, 2024 | 431,000.00 |
| Dec 31, 2023 | 515,000.00 |
| Sep 30, 2023 | 468,000.00 |
| Jun 30, 2023 | 781,000.00 |
| Mar 31, 2023 | 683,000.00 |